Xinli Lu

Dr. Xinli Lu


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2017 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
XLXinli Lu
Xinli Lu
HZHongru Zhao
Hongru Zhao
YZYuqi Zhang
Yuqi Zhang
Wei WangWei Wang
Wei Wang
CZCuiying Zhao
Cuiying Zhao
SCSuliang Chen
Suliang Chen
To understand HIV-1 drug resistance in 11 prefectures of Hebei Province, China, we implemented a cross-sectional HIV-1 molecular epidemiological survey. Blood samples were collected from 122 newly diagnosed drug-naïve HIV-1-positive individuals and 229 antiretroviral therapy (ART)-failure individuals from 11 prefectures in Hebei Province, China. Patient demographic data were obtained via face-to-face interviews using a standardized questionnaire when blood samples were collected. Genotyping of HIV-1 drug resistance (DR) was implemented using an in-house assay. In this study, the overall prevalence of HIV-1 DR was 35.5%. The prevalence of HIV-1 DR in participants experiencing treatment failure and ART-naïve participants was 51.9 and 5.9%, respectively. Mutations in protease inhibitors, nucleoside reverse transcriptase inhibitors (NRTIs), and non-NRTI (NNRTIs), as well as dual and multiple mutations were extensively seen in participants experiencing treatment failure. The proportions of NNRTI mutations (χ2 = 9.689, p = 0.002) and dual mutations in NRTIs and NNRTIs (χ2 = 39.958, p < 0.001) in participants experiencing treatment failure were significantly higher than those in ART-naïve participants. The distributions of M184V/I and M41L mutations differed significantly among three main HIV-1 genotypes identified. Viral load, symptoms in the past 3 months, CD4 counts, transmission route, and the duration of ART were found to be associated with HIV-1 DR. Our results suggest that new prevention and control strategies should be formulated according to the epidemic characteristics of HIV-1-resistant strains in Hebei Province, where antiretroviral drugs are widely used.

19 January 2016 in AIDS Research and Therapy
Verified
Journal Article
Open access
PDF file
XLXinli Lu
Xinli Lu
CZCuiying Zhao
Cuiying Zhao
Wei WangWei Wang
Wei Wang
CNChenxi Nie
Chenxi Nie
YZYuqi Zhang
Yuqi Zhang
XLXinli Lu
Xinli Lu
Since the first HIV-1 case in 1989, Hebei province has presented a clearly rising trend of HIV-1 prevalence, and HIV-1 genetic diversity has become the vital barrier to HIV prevention and control in this area. To obtain detailed information of HIV-1 spread in different populations and in different areas of Hebei, a cross-sectional HIV-1 molecular epidemiological investigation was performed across the province. Blood samples of 154 newly diagnosed HIV-1 individuals were collected from ten prefectures in Hebei using stratified sampling. Partial gag and env genes were amplified and sequenced. HIV-1 genotypes were identified by phylogenetic tree analyses. Among the 139 subjects genotyped, six HIV-1 subtypes were identified successfully, including subtype B (41.0 %), CRF01_AE (40.3 %), CRF07_BC (11.5 %), CRF08_BC (4.3 %), unique recombinant forms (URFs) (1.4 %) and subtype C (1.4 %). Subtype B was identified as the most frequent subtype. Two URF recombination patterns were the same as CRF01_AE/B. HIV-1 genotype distribution showed a significant statistical difference in different demographic characteristics, such as source (P < 0.05), occupation (P < 0.05) and ethnicity (P < 0.05). The distributions of subtype B (P < 0.05), CRF01_AE (P < 0.05), CRF07_BC (P < 0.05) and subtype C (P < 0.05) showed significant differences in all ten prefectures, and the distributions of all six subtypes were significantly different in Shijiazhuang (P < 0.05) and Xingtai (P < 0.05), but not in other prefectures (P > 0.05). The differences in HIV-1 genotype distribution were closely associated with transmission routes. Particularly, all six subtype strains were found in heterosexuals, showing that HIV-1 has spread from the high-risk populations to the general populations in Hebei, China. In addition, CRF01_AE instead of subtype B has become the major strain of HIV-1 infection among homosexuals. Our study revealed HIV-1 evolution and genotype distribution by investigating newly diagnosed HIV-1 individuals in Hebei, China. This study provides important information to enhance the strategic plan for HIV prevention and control in China.

28 January 2025 in Depression and Anxiety
Verified
Journal Article
Open access
ZWZhongqing Wang
Zhongqing Wang
FWFang Wang
Fang Wang
XLXinli Lu
Xinli Lu
FMFanyu Meng
Fanyu Meng
HGHaoxin Guo
Haoxin Guo
NLNannan Li
Nannan Li
Objective: Interest in the study of anxiety disorders is growing rapidly. However, there is still a lack of comprehensive bibliometrics research in measuring and analyzing global scientific publications. The aim of this article is to review the current research status and trends of anxiety disorders worldwide through bibliometrics and to provide reliable support for future in‐depth research. Methods: In this bibliometric study, we utilized VOSviewer to evaluate the Web of Science Core Collection (WoSCC) publications and to build visualizing maps to analyze the research progress on this topic between January 1, 2000, and August 7, 2024. Results: Up to August 7, 2024, the study included a total of 67,386 English original articles and review articles published in 4054 journals by 206,496 authors from 164 countries/regions. The United States was a leader in articles, researchers, and institutions in the field of anxiety disorders. Using cluster analysis, the keywords were divided into five major clusters: (1) etiology and pathogenesis, (2) clinical classification and interventions, (3) comorbidity, (4) anxiety caused by the COVID‐19 pandemic and specific groups, and (5) anxiety disorders in children and adolescents. Conclusion: Molecular and neural circuit mechanisms, adolescent psychological problems, objective indicators of diagnosis and classification, and technology‐assisted therapy are still the focus of future research. The findings provide a comprehensive overview of anxiety disorder research, which may help physicians, researchers, and local authorities and community health staff to more fully understand trends and influence in the field and highlight under‐researched areas, which could be the basis for future research.

1 April 2017 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
XLXinli Lu
Xinli Lu
XKXianjiang Kang
Xianjiang Kang
YLYongjian Liu
Yongjian Liu
YLYan Li
Yan Li
SCSuliang Chen
Suliang Chen
XLXinli Lu
Xinli Lu
Sexual exposure has been the predominant route of HIV-1 spread in Hebei Province, China. However, little information is available on HIV-1-transmitted drug resistance (TDR) among HIV-1-infected youths aged 16 to 25 years who are infected with HIV-1 and sexually active. In this study, the overall prevalence of TDR was 6.6% (10/152), a moderate level (5.0%–15.0%) according to World Health Organization Threshold Survey guidelines. However, the prevalence of TDR to protease inhibitors and nonnucleoside reverse transcriptase inhibitors was 4.6% (7/152) and 2.0% (3/152), respectively, which correspond to a low level (<5.0%). All TDR mutations (M46L/I, Y181C, K101E, and G190E) were found only in youths infected with HIV-1 through sexual activity. The prevalence of TDR among heterosexuals (10.0%, 3/30) was higher than that among men who have sex with men (5.8%, 7/120). TDR mutations resided in CRF01_AE (M46I/L and G190E) and subtype B (Y181C and K101E). Our findings will provide useful information on which drug regimens to use in treating the newly infected people with HIV-1.